Clinical trials
Ventricular Tachycardia clinical trials
Below are recruiting ventricular tachycardia clinical trials, each written for real people, not researchers. We’re tracking 75 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04976348Recruiting
Heart monitoring registry for teens and adults with heart symptoms
This study registers people who are referred to cardiology or genetics for heart-failure–type symptoms or heart/cardiogenetic screening. It helps doctors understand how monitoring platforms may support diagnosis and follow-up.
Maastricht, LimburgAges 16 years+ - NCT07018648Recruiting
Testing a wearable heart monitor for rhythm problems
This trial tests a chest belt that works with your smartphone to track heart rhythms. It may help if you have or might have an irregular heartbeat.
Olomouc, CzechiaAges 18 years+ - NCT06730464Recruiting
Predicting dangerous heart rhythms in non-ischemic heart disease
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
Milan, ItalyAges 18 years+ - NCT04189822Enrolling by invitation
Heart rhythm genetic registry and blood sample bio bank
This study is building a Canadian database and tissue/blood bank for people and families with inherited heart rhythm conditions (and some inherited heart muscle diseases). It collects consented health and genetic information to help researchers better understand who is at risk and how these conditions work.
Vancouver, British ColumbiaAges Any age - NCT06255457Recruiting
Heart rhythm study for patients getting mitral valve surgery
This study looks at heart rhythm problems in people having mitral valve surgery to fix a leaky valve. It may help doctors better understand who is at risk for dangerous rhythms.
Stockholm, Stockholm CountyAges 18 years+ - NCT06730607Recruiting
Predicting heart rhythm problems after myocarditis
This study uses heart MRI scans to predict who might develop dangerous heart rhythms after recovering from myocarditis. It aims to find better ways to monitor patients and prevent emergencies.
Rozzano, MilanAges 18 years+ - NCT06546137Recruiting
Registry for inherited heart conditions in Brazil
This study is building a national registry in Brazil to learn more about inherited heart conditions and improve care. If you have a family-related heart disease, you may be able to join and help advance cardiovascular healthcare.
Rio Branco, AcreAges Any age - NCT06931821Recruiting
Mapping to guide ablation for ventricular tachycardia
This study tests a new way to map the heart's electrical activity to guide a procedure that destroys the tissue causing fast, dangerous heart rhythms. It's for people with heart disease and ventricular tachycardia that hasn't been controlled by medication.
Phoenix, ArizonaAges 18 years+ - NCT04162171Recruiting
SBRT treatment study for steady heart rhythm VT
This study looks at using SBRT (high-precision radiation) to treat a dangerous, steady heart rhythm called monomorphic VT. It is meant for people who keep having VT even after prior ablation attempts and after trying a class III “rhythm-stabilizing” medicine.
Halifax, Nova ScotiaAges Any age - NCT04499326Recruiting
Improve quality-of-life reporting after defibrillator heart ablation
This study looks at how to better track patients’ quality of life (how you feel and function) after catheter ablation for a dangerous heart rhythm, using questionnaires you complete. It may help the care team understand how to measure patient outcomes more accurately after treatment.
LondonAges 18 years+ - NCT05236153Recruiting
Study of heart valve procedure in repaired Tetralogy of Fallot
This study looks at how a transcatheter pulmonary valve replacement works in people with repaired Tetralogy of Fallot or double outlet right ventricle. The goal is to better understand the heart’s anatomy and how it may affect the valve procedure.
Boston, MassachusettsAges Any age - NCT05337241Recruiting
Saline enhanced needle ablation for stubborn heart rhythm
This trial studies a special “needle” ablation method (with saline) to treat a dangerous, repeat heart rhythm problem called monomorphic ventricular tachycardia (VT). It’s for adults whose VT keeps coming back despite prior treatments and who may not benefit from another standard ablation.
Birmingham, AlabamaAges 18 years+ - NCT05377216RecruitingEarly Phase 1
Testing nerve stimulation effects during heart ablation
This trial studies how a type of nerve stimulation affects the heart’s electrical signals during a procedure to treat a dangerous fast heart rhythm (ventricular tachycardia). It may help doctors better understand safety and effects during planned ablation.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05439031RecruitingPhase 2
Stereotactic radiation to reduce recurrent dangerous heart rhythm episodes
This Phase 2 study tests a precise form of radiation therapy to control recurrent ventricular tachycardia (VT), a dangerous fast heart rhythm. It may help people whose VT keeps coming back despite heart medicines and/or ablation, especially when ablation is not possible.
Amsterdam, North HollandAges 18 years+ - NCT05543798Recruiting
MRI-guided heart procedure for dangerous abnormal rhythms
This trial studies a heart rhythm procedure (“ablation”) for people with ischemic cardiomyopathy who have ongoing episodes of sustained ventricular tachycardia. It aims to reduce these dangerous rhythm events, especially when standard anti-rhythm medications don’t work or can’t be used.
Leipzig, SaxonyAges 18 years+ - NCT05599022Recruiting
Testing TcMS to stop dangerous fast heart rhythms
This trial tests a treatment called TcMS to reduce episodes of dangerous fast heart rhythm (VT) or shocks from an implanted heart device. It may help people who keep having these episodes even after taking at least one anti-arrhythmia medicine.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05835791Recruiting
Study of new ventricular arrhythmia patients getting ICD follow-up
This study looks at people who are newly diagnosed with a dangerous heart rhythm called ventricular tachycardia (VT) and who are getting an implantable cardioverter-defibrillator (ICD). It may help improve how patients are followed in the ICD clinic after the initial hospitalization.
Vancouver, British ColumbiaAges 18 years+ - NCT05841199Recruiting
Study heart blood flow during fast heart rates
This study measures how well blood flows through the heart when the heart rate is increased during a heart procedure. It may help doctors better understand coronary (heart artery) blood flow and how to guide treatment when you need angiography or angioplasty.
LondonAges 18 years+ - NCT06371729Recruiting
Comparing two heart mapping methods for VT ablation
This trial tests two different ways of mapping the heart to guide treatment for a dangerous fast heart rhythm. The goal is to see which mapping method works better for people with an ICD who need a procedure called ablation to stop the rhythm.
Milan, LombardyAges 18 years+ - NCT06658899RecruitingPhase 2
Study of CRD-4730 for CPVT (rare heart rhythm disorder)
This study tests an experimental drug called CRD-4730 for people with CPVT, a rare inherited heart rhythm disorder that can cause dangerous fast heartbeats during exercise or stress. The trial will see if the drug can help control these abnormal heart rhythms better than current treatments.
San Francisco, CaliforniaAges 18–99 - NCT06543173Recruiting
Preventive heart ablation with defibrillator in high-risk patients
This study tests if doing a special heart procedure (catheter ablation) at the same time as implanting a defibrillator (ICD) can prevent dangerous heart rhythms better than the ICD alone. It is for people with a very weak heart pump due to blocked arteries who are getting a first-time ICD.
Copenhagen, Region HAges 18 years+ - NCT06937983Recruiting
Mapping to guide heart rhythm treatment
This study tests a new way of mapping damaged heart muscle to improve the precision of a procedure called catheter ablation, which treats dangerously fast heart rhythms. It may help people with heart disease who need this procedure.
Coventry, West MidlandsAges 18 years+ - NCT07024927Recruiting
Heart rhythm disorder registry
This study observes people with atrial fibrillation or ventricular tachycardia who are having their first catheter ablation procedure. The goal is to collect information to improve future treatments.
Beijing, Beijing MunicipalityAges 18 years+ - NCT02413450Enrolling by invitation
Using patient DNA cells to study inherited heart rhythm risks
This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.
Baltimore, MarylandAges 18–85
Hear when a new Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventricular tachycardia?
- Yes. Clin2 currently lists 75 recruiting ventricular tachycardia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventricular tachycardia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventricular tachycardia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.